Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
257.00    -3.00 (-1.15%)
Bid:
251.00
Ask:
257.00
Spread: 6.00 (2.39%)
Market Cap: £230.16m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Director/PDMR Shareholding

24 Feb 2022 07:00

RNS Number : 6097C
Wilmington PLC
24 February 2022
 

24 February 2022

Wilmington plcDirector/PDMR Shareholding

On 22 February 2022, nil cost awards over 34,577 ordinary shares in Wilmington plc (the "Company") and options with a per share exercise price of £2.42 over 10,905 ordinary shares in the Company were granted under the Wilmington Performance Share Plan 2017 (the "Plan") to employees of the Company and its subsidiaries, of which the following nil cost awards were made to Directors of the Company and other Persons Discharging Managerial Responsibilities ("PDMRs"):

Name of Director/PDMR

Number of shares under the Award

Ruth Abdey (PDMR)

27,307

No consideration was paid for the grant of the awards. The vesting of the awards and options is subject to the satisfaction of performance conditions, which will be assessed over three years. The performance conditions applicable to the awards granted to the PDMR are outlined below:

Final Year EPS

Extent to which the EPS Performance Condition is satisfied

21.5 pence or more than 21.5 pence

100%

More than 18.0 pence but less than 21.5 pence

On a straight line basis between 25% and 100%

18.0 pence

25%

Less than 18.0 pence

0%

 

Organic Revenue Growth CAGR

Extent to which the Strategic Performance Condition is satisfied

9% or more than 9%

100%

More than 7% but less than 9%

On a straight line basis between 25% and 100%

7%

25%

Less than 7%

0%

 

Underpin Performance Condition

The performance condition will be satisfied if average Return on Capital Employed 'ROCE' over the performance period is at least 10%.

The awards granted to the Executive Directors and other PDMRs are subject to an additional condition that ordinarily all of the shares acquired (after sales to cover tax) must be retained until the second anniversary of the vesting date.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

For further information, please contact:

Wilmington plc 020 490 0049

Guy Millward

Chief Financial Officer and Company Secretary

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs close to 1,000 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

Ruth Abdey

2.

Reason for the notification

 

a)

Position /status

Chief People Officer

b)

Initial notification / amendment 

Initial Notification

3.

Details of the Issuer 

a)

Name

Wilmington plc

 

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares in Wilmington plc

ISIN: GB0009692319

b)

Nature of the transaction

Grant of award over Ordinary Shares under the Company's Performance Share Plan 2017

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil Cost

27,307

d)

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

e)

Date of the transaction

22 February 2022

f)

Place of the transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTJMATMTBTBTT
Date   Source Headline
17th Apr 202611:20 amRNSHolding(s) in Company
15th Apr 20263:56 pmRNSBoard changes
15th Apr 202611:21 amRNSSave As You Earn Options
11th Mar 202611:00 amRNSDirector Declaration
11th Mar 202611:00 amRNSDirector Declaration
26th Feb 20267:00 amRNSHalf-year Financial Report
11th Feb 20262:44 pmRNSNotice of half year-end results
21st Jan 202611:19 amRNSNotice of Half Year Results
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
5th Dec 20259:56 amRNSAcquisition of Conversia completed
28th Nov 20254:23 pmRNSDirector/PDMR Shareholding
28th Nov 202511:22 amRNSAcquisition of Conversia cleared to complete
25th Nov 20259:19 amRNSResult of AGM
10th Nov 20255:54 pmRNSDirectorate change
1st Oct 20252:51 pmRNSDirector/PDMR Shareholding
1st Oct 20252:49 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights
22nd Sep 202512:48 pmRNSDirector/PDMR Shareholding- Replacement
22nd Sep 202511:52 amRNSDirector/PDMR Shareholding
22nd Sep 20257:00 amRNSFinancial results for the year ended 30 June 2025
5th Sep 202510:58 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSNotice of year-end results
29th Aug 202511:07 amRNSHolding(s) in Company
12th Aug 20257:03 amRNSProposed acquisition of Conversia
12th Aug 20257:00 amRNSDirector Declaration
1st Aug 20257:00 amRNSAppointment of Joint Corporate Broker
30th Jul 20257:00 amRNSStatement in relation to a potential acquisition
23rd Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20259:00 amRNSDirector/PDMR Shareholding
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20259:30 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.